Biodexa Pharmaceuticals Plc ADR (BDRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Sales | 0 | 0 | 474 | 865 | 795 |
| Gross Profit | N/A | N/A | 474 | 865 | 795 |
| Operating Expenses | 11,400 | 11,755 | 10,443 | 11,913 | 10,418 |
| Operating Income | -11,400 | -11,755 | -9,969 | -11,048 | -9,623 |
| Interest Expense | 302 | 211 | 51 | 66 | 61 |
| Other Income | 3,145 | 4,326 | 709 | 615 | 1,287 |
| Pre-tax Income | -8,557 | -7,641 | -9,311 | -10,499 | -8,396 |
| Income Tax | -139 | -320 | -505 | -1,029 | -888 |
| Net Income Continuous | -8,419 | -7,321 | -8,806 | -9,470 | -7,508 |
| Net Income | $-8,419 | $-7,321 | $-8,806 | $-9,470 | $-7,508 |
| EPS Basic Total Ops | -76.73 | -638.95 | -12,439.00 | -958,600.00 | -0.48 |
| EPS Basic Continuous Ops | -76.73 | -739.09 | -13,939.48 | -958,084.40 | -0.47 |
| EPS Diluted Total Ops | -76.73 | -638.95 | -12,439.00 | -958,600.00 | -0.48 |
| EPS Diluted Continuous Ops | -76.73 | -739.09 | -13,939.48 | -958,084.40 | -0.47 |
| EPS Diluted Before Non-Recurring Items | -13.19 | -127.80 | -2,487.50 | -191,800.00 | -192,000.00 |
| EBITDA(a) | $-11,151 | $-11,431 | $-9,617 | $-10,624 | $-9,069 |